Glenmark Pharmaceuticals Ltd (GPL) has agreed to divest 75 per cent stake in its subsidiary Glenmark Life Sciences to Nirma Limited at a price of Rs 615 per share, implying an equity valuation of Rs 7,535.4 crore.
The research-led, integrated, global pharmaceutical company has entered into a definitive agreement with Nirma Limited to divest 75 per cent stake in its subsidiary, Glenmark Life Sciences (GLS), at a price of Rs 615 per share for an aggregate consideration of Rs 5,651.5 crore, subject to closing adjustments.
Glenmark Pharma will own 7.84 per cent in GLS after the divestment. The transaction is subject to customary closing conditions precedent, including receipt of regulatory and shareholder approvals.
Pursuant to the transaction, Nirma Limited will make a mandatory open offer to all the public shareholders of GLS.
GPL expects to utilise the proceeds of the sale to repay debt and become net cash positive.
Upon the completion of the transaction and the open offer, the buyer will become the new promoter of the company. GPL will retain 9,609,571 equity shares representing 7.84 per cent of the current issued and paid-up equity share capital of the company.
Pursuant to the transaction, GPL and the other member of the promoter group are proposed to be reclassified as public shareholders.
GPL has agreed that it shall not sell the equity shares retained by it upon the completion of the transaction until the earlier of one year from the closing under the share purchase agreement and one month from the date of compliance with minimum public shareholding requirements by the company and the buyer.
VC funding drops 22.5 pc in China in Jan-Nov as India sees surge
As venture capital (VC) funding surged in India this year, China saw a 22.5 per cent decline in VC funding by both volume and value in the January-November period, a report showed on Thursday.
Indian share market opens in green, Nifty above 23,800
At around 9:37 am, Sensex was trading at 78,744.55 after gaining 271.68 points or 0.35 per cent, while the Nifty was trading at 23,812.50 after gaining 84.85 points or 0.36 per cent.
Indian share market ends in red ahead of key global policy decisions
Ahead of key policy decisions especially from the US Federal Reserve, the Indian stock market closed in red on Tuesday as selling was seen in the PSU bank, auto, IT, financial service, pharma, FMCG, metal, and realty sectors of Nifty.
Buy on dips strategy working well in Indian stock market amid sharp rebound
The surge in the Indian stock market on Friday helped the Indian benchmark indices end the week on a positive note. A strong 2,000-point rebound from the lows suggests that the buy-on-dips strategy is working well in the market, experts said on Saturday.
India’s GDP growth to hold steady in FY25, likely to clock 6.7 pc in FY26
India's economic growth will continue to hold steady in FY25 despite global uncertainties, with a projected GDP at 6.7 per cent in FY26, a report showed on Friday.
Share market ends lower ahead of CPI data, Sensex settles at 81,289
According to experts, "the market continued to remain range bound ahead of domestic CPI data and weakening rupee. Though inflation is anticipated to drop, investors are maintaining a close vigil on the vegetable prices, which will determine the future rate trajectory."
Indian share market opens higher ahead of CPI data
The Indian stock market opened higher on Thursday ahead of the consumer price index (CPI) data. In the early trade, selling was seen in Nifty's auto and PSU bank sectors.
Tira unveils its flagship luxury beauty store at Jio World Plaza
Tira, the beauty retail chain of Reliance Retail, unveils its luxury flagship store today at Jio World Plaza, Mumbai which is poised to elevate the beauty shopping experience to unprecedented heights, offering an experience that is comparable with the best of global standards in luxury beauty retail.